Palisade Bio Inc (PALI)
4.76
+0.15
(+3.25%)
USD |
NASDAQ |
May 31, 16:00
4.81
+0.05
(+1.05%)
After-Hours: 20:00
Palisade Bio Price to Book Value: 0.443 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.443 |
| May 30, 2024 | 0.429 |
| May 29, 2024 | 0.4197 |
| May 28, 2024 | 0.443 |
| May 24, 2024 | 0.4569 |
| May 23, 2024 | 0.4802 |
| May 22, 2024 | 0.4802 |
| May 21, 2024 | 0.5035 |
| May 20, 2024 | 0.5444 |
| May 17, 2024 | 0.5919 |
| May 16, 2024 | 0.6012 |
| May 15, 2024 | 0.5945 |
| May 14, 2024 | 0.5815 |
| May 13, 2024 | 0.5796 |
| May 10, 2024 | 0.6253 |
| May 09, 2024 | 0.6467 |
| May 08, 2024 | 0.6579 |
| May 07, 2024 | 0.7361 |
| May 06, 2024 | 0.7874 |
| May 03, 2024 | 0.6549 |
| May 02, 2024 | 0.6168 |
| May 01, 2024 | 0.5991 |
| April 30, 2024 | 0.5102 |
| April 29, 2024 | 0.5229 |
| April 26, 2024 | 0.5119 |
| Date | Value |
|---|---|
| April 25, 2024 | 0.5272 |
| April 24, 2024 | 0.5373 |
| April 23, 2024 | 0.5009 |
| April 22, 2024 | 0.4172 |
| April 19, 2024 | 0.3985 |
| April 18, 2024 | 0.429 |
| April 17, 2024 | 0.5585 |
| April 16, 2024 | 0.5018 |
| April 15, 2024 | 0.352 |
| April 12, 2024 | 0.3486 |
| April 11, 2024 | 0.3706 |
| April 10, 2024 | 0.3444 |
| April 09, 2024 | 0.4586 |
| April 08, 2024 | 0.5102 |
| April 05, 2024 | 0.4689 |
| April 04, 2024 | 0.4867 |
| April 03, 2024 | 0.4937 |
| April 02, 2024 | 0.4853 |
| April 01, 2024 | 0.4952 |
| March 28, 2024 | 0.4506 |
| March 27, 2024 | 0.4463 |
| March 26, 2024 | 0.4209 |
| March 25, 2024 | 0.4096 |
| March 22, 2024 | 0.4224 |
| March 21, 2024 | 0.4401 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2233
Minimum
Dec 27 2022
9.746
Maximum
Nov 03 2021
1.798
Average
0.7594
Median
Jan 23 2023
Price to Book Value Benchmarks
| TG Therapeutics Inc | 15.74 |
| Protagenic Therapeutics Inc | 2.745 |
| Bio-Path Holdings Inc | -- |
| Intra-Cellular Therapies Inc | 11.84 |
| Jaguar Health Inc | 1.720 |
Price to Book Value Related Metrics
| Price | 4.76 |
| Earnings Yield | -496.6% |
| Market Cap | 4.457M |